Core Viewpoint - Jichuan Pharmaceutical (600566.SH) announced that its wholly-owned subsidiary, Shaanxi Dongke Pharmaceutical Co., Ltd., has received the drug registration certificate for Lidocaine Gel Patch from the National Medical Products Administration [1] Group 1: Company Information - The company is involved in the pharmaceutical industry, specifically focusing on the development and production of local anesthetics [1] - Lidocaine is classified as an amide-type local anesthetic, which functions by stabilizing the nerve cell membrane through the inhibition of ion channels necessary for nerve impulse generation and conduction [1] Group 2: Regulatory Approval - The approval from the National Medical Products Administration signifies a regulatory milestone for the company, allowing it to market the Lidocaine Gel Patch [1]
济川药业子公司取得利多卡因凝胶贴膏药品注册证书